Kalms Consulting GmbH of Berlin at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine

Kalms Consulting GmbH

Rheinstr. 45-46, 12161 Berlin
Germany
Telephone +49 30 405045320
Fax +49 30 405045329
info@kalmsconsulting.com

This company is co-exhibitor of
Berlin Partner für Wirtschaft und Technologie GmbH

Hall map

MEDICA 2018 hall map (Hall 15): stand F42

Fairground map

MEDICA 2018 fairground map: Hall 15

Our range of products

Product categories

  • 07  Medical Services and Publications
  • 07.10  Consulting services for health organisations

Consulting services for health organisations

Our products

Product category: Consulting services for health organisations

Market Assessment

Planning A Flawless New Product Launch
With still ongoing or after already completed initiatives on securing reimbursement in the German sectorial healthcare environment, the appropriate moment of launching your product in the market must be considered. The key strategic decision about the legal construct of a product distribution or even funding of a legal entity for a local organization must be made.

Another perspective for assessing the local market – beyond its potential for health care – is required. Now structural, the health care related infrastructure especially, demographic, logistical and finally management and personnel questions must be answered and merged with your product’s specific application and service requirements.

Your business plan, which then is built on our pre-commercialization market assessment moves into the final phase and therefore needs reliable facts to build the comprehensive and solid base for your investment into the target market, which finally is fundament for the creation of the return on all your prior efforts.

Unlike other consultants, Kalms Consulting doesn’t end its collaboration with its clients at this conceptual endpoint. At Kalms Consulting, we collected some dozens of man-years of business experience, especially in leadership, management and operational execution of marketing and sales functions for world-class medical device companies. We bring this to the table for you, for purposes of “testing the water” for your product before a final commercialization decision and the investment for it is made. In fact, we also offer our interim management and product distribution capabilities after the launch for bridging your activities until your enterprise is operating self-sufficient and successfully in the market.

The German Healthcare System
The German statutory health insurance system can successfully manage the expenditure growth limit dictated by social legislation. This capability is result of the centralized maintenance of the reimbursement systems in the two separated care sectors: hospital and out-patient care. While innovative methods with potential to be required for patient’s care can be immediately utilized in hospitals, such methods need to undergo a G-BA benefit assessment before statutory reimbursement in ambulatory care is granted.

In the last decades, the German health system is pushed towards integrated care solutions to overcome sectorial borders and their limitations for acute patient’s care. Meanwhile, evidence-based health care plays a dominant role and will become incentivized with new reimbursement schemes for both sickness funds and providers to improve quality and efficiency of care.

Kalms Consulting owns the knowledge about this systemic context, which is fundamental to define the market access process for innovative products representing an unprecedented theoretic-scientific concept. We are experienced in the execution of required steps before launching a commercial operation should be considered.

More Less

Product category: Consulting services for health organisations

Reimbursement Strategies

Reimbursement Applications

We develop reimbursement strategies. We focus on preparing and implementing reimbursement applications in Germany and selected markets thus ensuring that the requirements and submission deadlines of healthcare authorities are met.

Obtaining Reimbursement
Obtaining reimbursement can often be a long term project and success depends on various factors, terms and regulations. Our experts will inform you about the opportunities and potential risks of this.

More Less

About us

Company details

Real Experts For Your Market Success
Kalms Consulting offers a complete consultancy service for medical device manufacturers and selected services for pharmaceutical companies. Based in Berlin, we support your business success in Europe thanks to our expertise in the medical device market in Germany.

We are your gateway to one of the biggest medical technology markets in the world. Marco Kalms and his team have over twenty years of operational and strategic business experience in Europe, including sales and country management in various European leadership roles.

We offer strategic and operational support in the fields of market access, health economics, reimbursement and business development.

Our strong network of qualified associates guarantees full coverage of the areas of consulting we provide – from market assessments to public relations and public affairs.

Our sister company, Kalms Operations provides full logistical support, and services, on your request.

Solutions Tailored To Your Individual Needs
With your success in mind, we develop tailor-made pathways that match your individual needs. We keep you up to date about relevant changes in the market.

We do not work with standardized concepts – instead we provide you with practical solutions. Our experts take care of your entrepreneurial issues and will develop your projects from strategy to real business.

Germany, The Leading Market In Europe
Germany is a market that has great opportunities for medical devices. This isn’t just because there are 82 million inhabitants living in a wealthy and aging society, and this isn’t just because of the economic, legal and political stability that exists.

YOUR OPPORTUNITIES IN GERMANY
There are three more key arguments as to why you should do business here in Germany:

  1. Market access is comparably open in the hospital sector. Hospitals are reimbursed for implementing new methods but; on the basis that they are not actively excluded.
  2. The German health system is one that is well financed and independent of the State budget. This means that public health funds and private insurance companies have the ability to finance innovative projects and procedures.
  3. Germany is a leading market for medical technologies and is also benchmark for reimbursement and pricing. Performing well and demonstrating success in Germany is an important reference point for HTA bodies and customers in other countries.
The German health system may indeed have complex decision-making structures and challenge; such as benefit assessments for certain new methods or changes by the upcoming EU medical device regulation, but this isn’t a reason for you to miss out on the opportunities available to you in Germany. You shouldn’t let this reason to cause you to miss out on the opportunities available to you in Germany. It’s actually a compelling reason for you to make use of the professional advice Kalms Consulting offers; thanks to our qualified and experienced team.

More Less